Validity of cancer-related fatigue instruments.

Abstract:

:Fatigue is one of the most debilitating and common symptoms associated with hematologic and oncologic disorders and treatment strategies. Patient factors influence etiology and symptom manifestation, which in turn affect diagnosis, management, and monitoring. Fatigue instruments can assist with the identification, management, and monitoring of this difficult and debilitating process. A variety of fatigue instruments have been developed, several of which have been validated in patients with cancer. Psychometric confirmation is difficult because of the diverse nature of cancer-related fatigue. Prospective, comparative, and combination analyses of the developed instruments are required to confirm validation and clarify use in practice.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Schwartz AH

doi

10.1592/phco.22.16.1433.33690

subject

Has Abstract

pub_date

2002-11-01 00:00:00

pages

1433-41

issue

11

eissn

0277-0008

issn

1875-9114

journal_volume

22

pub_type

杂志文章,评审
  • Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group.

    abstract::Concerns about cross-allergenicity between sulfonamide antibiotics and nonantibiotic, sulfonamide-containing drugs persist and can complicate patients' drug therapy unnecessarily. No interaction between the human immune system and the sulfonamide functional group has been demonstrated. The immunologic determinant of t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.9.856.36106

    authors: Brackett CC,Singh H,Block JH

    更新日期:2004-07-01 00:00:00

  • The pharmacokinetics and pharmacodynamics of fludarabine in rheumatoid arthritis.

    abstract:STUDY OBJECTIVE:To describe the pharmacokinetics and pharmacodynamics of fludarabine in patients with rheumatoid arthritis (RA). DESIGN:Open-label, staggered trial conducted in conjunction with a phase I-II clinical trial. SETTING:Government research hospital. PATIENTS:Twenty-six patients with refractory RA. INTERV...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Knebel W,Davis JC Jr,Sanders WD,Fessler B,Yarboro C,Pucino F,Boumpas DT

    更新日期:1998-11-01 00:00:00

  • Prolonged paralysis associated with long-term pancuronium use.

    abstract::We cared for a 4-year-old patient who had undergone orthotopic liver transplantation and was placed on a ventilator for respiratory distress associated with Pneumocystis carinii pneumonia. The neuromuscular blocking agent pancuronium bromide 1.0-1.2 mg every hour as needed was used to facilitate artificial ventilation...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.1989.tb04121.x

    authors: Haas JL,Shaefer MS,Miwa LJ,Wood RP,Shaw BW Jr

    更新日期:1989-01-01 00:00:00

  • Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis.

    abstract:STUDY OBJECTIVE:To evaluate the success of an initial tobramycin dosing regimen to achieve target peak and trough concentrations in adult patients with pulmonary exacerbations of cystic fibrosis (CF). DESIGN:Retrospective single-center medical record review. SETTING:Large tertiary care academic medical center. PATIE...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1762

    authors: Staubes BA,Metzger NL,Walker SD,Peasah SK

    更新日期:2016-06-01 00:00:00

  • Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy, safety, and costs of rabbit antithymocyte globulin (TMG) induction in patients who received kidney transplants from living unrelated donors. DESIGN:Retrospective cohort study. SETTING:Large academic medical center. PATIENTS:Eighty-seven patients who received kidney transplan...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.10.1166

    authors: Miller JT,Collins CD,Stuckey LJ,Luan FL,Englesbe MJ,Magee JC,Park JM

    更新日期:2009-10-01 00:00:00

  • Dapagliflozin: a novel sodium-glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.

    abstract::The prevalence of diabetes mellitus has grown to staggering numbers, and its incidence is expected to rise in the next 2 decades. The need for novel approaches to treat hyperglycemia cannot be ignored. Current agents have been shown to modestly improve glycemia and in some cases prevent complications of diabetes, but ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/PHAR.1010

    authors: Shah NK,Deeb WE,Choksi R,Epstein BJ

    更新日期:2012-01-01 00:00:00

  • Do Electronic Cigarettes Have a Role in Tobacco Cessation?

    abstract::Tobacco use continues to be a major cause of morbidity and mortality. Even with behavioral and pharmacologic treatment, long-term tobacco cessation rates are low. Electronic nicotine delivery systems, commonly referred to as electronic cigarettes or e-cigarettes, are increasingly used for tobacco cessation. Because e-...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2103

    authors: Franks AS,Sando K,McBane S

    更新日期:2018-05-01 00:00:00

  • Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.

    abstract:STUDY OBJECTIVE:To assess the reproducibility of Naranjo Adverse Drug Reaction Probability Scale (APS) scores in published case reports. DESIGN:Reliability analysis. MEASUREMENTS AND MAIN RESULTS:Randomly selected case reports using the APS were identified from the Web of Science database. The APS scores were blinded...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1496

    authors: Liang R,Borgundvaag B,McIntyre M,Thwaites C,Ragan K,Wyllie A

    更新日期:2014-11-01 00:00:00

  • Pharmacologic and pharmacokinetic comparison of antianginal agents.

    abstract::Calcium channel blockers, nitrates, and beta blockers are the primary agents used for the treatment of angina. Calcium has a central role in excitation-contraction, action potential generation, and ischemic cell death. The three currently available calcium antagonists are nifedipine, verapamil, and diltiazem. Second-g...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1987.tb04052.x

    authors: Angaran D

    更新日期:1987-01-01 00:00:00

  • Preliminary validation of self-assessment tool to measure imatinib adherence in patients with chronic myeloid leukemia.

    abstract:STUDY OBJECTIVES:To develop and validate a self-assessment adherence tool for imatinib in patients with chronic myeloid leukemia (CML), and to correlate the use of this tool with response to treatment and adverse effects. DESIGN:Retrospective cohort study. SETTING:Regional cancer center in France. PATIENTS:Forty-six...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1174

    authors: Daouphars M,Ouvry M,Lenain P,Rouvet J,Jardin F,Bubenheim M,Varin R

    更新日期:2013-02-01 00:00:00

  • Nonhormonal alternatives for the treatment of hot flashes.

    abstract:OBJECTIVE:To review the literature on clonidine, venlafaxine, selective serotonin reuptake inhibitors, and gabapentin for the treatment of hot flashes. DATA SOURCES:A MEDLINE search (January 1966-July 2003) was conducted to identify English-language literature available on the treatment of hot flashes that focused on ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.1.79.34812

    authors: Sicat BL,Brokaw DK

    更新日期:2004-01-01 00:00:00

  • The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.

    abstract::Two analyses were conducted to compare the cost-effectiveness of different intravenous immunoglobulin (IGIV) formulations: IGIV purified by caprylate precipitation and chromatography (IGIV-C) and IGIV manufactured by an older solvent-detergent method (IGIV-S/D). The results indicated that IGIV-C is associated with cos...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.2005.25.11part2.94S

    authors: Mahadevia PJ

    更新日期:2005-11-01 00:00:00

  • Is chlordiazepoxide the rational choice among benzodiazepines?

    abstract::Diazepam is frequently the subject of review by various agencies and institutions charged with determining whether or not to substitute another, more economical drug--in most instances, chlordiazepoxide. A review of the comparative literature has shown that, on clinical and pharmacokinetic grounds, chlordiazepoxide is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1982.tb03181.x

    authors: Baskin SI,Esdale A

    更新日期:1982-03-01 00:00:00

  • Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy and safety of a new combination product, enalapril-diltiazem ER, when administered over the long term. DESIGN:Open-label, titration to response, with treatment lasting 46 weeks after a 6-week, double-blind phase. SETTING:Medical clinics in the private and academic sectors. PA...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Applegate W,Cohen JD,Wolfson P,Davis A,Green S

    更新日期:1997-01-01 00:00:00

  • A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations.

    abstract:STUDY OBJECTIVE:To determine the usage patterns of the lipid-based amphotericin B formulations at our institution and to compare the observed nephrotoxicity and efficacy of these formulations. DESIGN:Prospective and retrospective observational study SETTING:Urban 350-bed teaching hospital. PATIENTS:Sixty-seven nonhe...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.21.13.1107.34613

    authors: Cannon JP,Garey KW,Danziger LH

    更新日期:2001-09-01 00:00:00

  • The effect of low-dose phenytoin on high-density lipoprotein cholesterol.

    abstract::We examined whether low doses of phenytoin, which should be associated with few dose-related side effects, may increase the levels of high-density lipoprotein (HDL) cholesterol. Of 35 healthy adult men who consented to participate, 31 completed the study. They took no medications and consumed no alcohol during the stu...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: McKenney JM,Petrizzi KS,Briggs GC,Wright JT Jr

    更新日期:1992-01-01 00:00:00

  • Clinical pharmacology of recombinant human erythropoietin (r-HuEPO).

    abstract::Recombinant human erythropoietin reverses the severe anemia associated with end-stage renal disease. Mean half-life values after a single intravenous bolus dose range from 4-13 hours. Renal clearance is not a significant route of elimination. Dosing schedules in chronic renal failure involve a single intravenous bolus...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Flaharty KK

    更新日期:1990-03-01 00:00:00

  • Anaphylactoid reaction to enoxaparin in a patient with deep venous thrombosis.

    abstract::A 40-year-old Caucasian man diagnosed with right deep venous thrombosis secondary to trauma was treated with subcutaneous enoxaparin. Within minutes of administering the first dose (1 mg/kg), he experienced an apparent anaphylactoid reaction; symptoms were abdominal pruritus, severe cough, shortness of breath, anxiety...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.16.1511.33688

    authors: MacLaughlin EJ,Fitzpatrick KT,Sbar E,Jewell C

    更新日期:2002-11-01 00:00:00

  • Postinduction carbamazepine clearance in an adult psychiatric population.

    abstract::The objective of this study was to describe the postinduction clearance of carbamazepine (CBZ) in adult psychiatric patients by population pharmacokinetic analysis using the NONMEM program. Specifically, an estimate of CBZ clearance and insight into the effect of common patient characteristics on clearance were sought...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Martin ES 3rd,Crismon ML,Godley PJ

    更新日期:1991-01-01 00:00:00

  • Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy.

    abstract::Meglumine antimoniate was administered to a patient with visceral leishmaniasis with normal renal function. Soon after the first intramuscular administration of meglumine antimoniate 20 mg/kg, equivalent to 510 mg antimony (Sb), the patient developed septic shock with oliguria. Creatinine clearance decreased to 23 ml/...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.13.1141.35032

    authors: Hantson P,Luyasu S,Haufroid V,Lambert M

    更新日期:2000-09-01 00:00:00

  • Antidepressants in the management of chronic pain syndromes.

    abstract::Conditions in which antidepressants have been used include diabetic neuropathy, postherpetic neuralgia, headaches, arthritis, chronic back pain, cancer, thalamic pain, facial pain, and phantom limb pain. Although much of the available information is derived from inadequately controlled trials, it seems that antidepres...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Egbunike IG,Chaffee BJ

    更新日期:1990-01-01 00:00:00

  • Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer.

    abstract:OBJECTIVE:To evaluate the effect of telephone follow-up on the physical well-being dimension of health-related quality of life in patients with cancer. DESIGN:Randomized, controlled trial. SETTING:Public teaching hospital. PATIENTS:One hundred fifty patients with cancer who were discharged to home from the hospital....

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.22.15.1301.33480

    authors: Beney J,Devine EB,Chow V,Ignoffo RJ,Mitsunaga L,Shahkarami M,McMillan A,Bero LA

    更新日期:2002-10-01 00:00:00

  • Genetic causes of clopidogrel nonresponsiveness: which ones really count?

    abstract::Clopidogrel decreases the morbidity and mortality associated with several cardiovascular diseases. However, clopidogrel is a prodrug that needs to be metabolized to the active thiol metabolite by the cytochrome P450 (CYP) system. This activation is a source of significant interindividual variability in clopidogrel res...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.30.3.265

    authors: Momary KM,Dorsch MP,Bates ER

    更新日期:2010-03-01 00:00:00

  • The biology of thrombin in acute coronary syndromes.

    abstract::Thrombin, a serine protease, is the keystone of the twin processes of hemostasis and thrombosis. Through procoagulant, anticoagulant, and antifibrinolytic mechanisms, thrombin helps maintain vascular integrity in the face of hemorrhage. These same mechanisms, however, allow for the pathologic formation of thrombi in r...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.10.90s.33617

    authors: Nappi J

    更新日期:2002-06-01 00:00:00

  • Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.

    abstract:STUDY OBJECTIVES:To determine the incidence of Clostridium difficile infection (CDI) at one community hospital by identifying patients with stool samples positive for C. difficile toxin A or B, and to compare the incidence with a 2008 national estimate; and to determine which patient characteristics and concomitant ant...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.7.642

    authors: King RN,Lager SL

    更新日期:2011-07-01 00:00:00

  • Elevations in serum creatinine concentration: concerning or reassuring?

    abstract::The use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) has significantly reduced morbidity and mortality across the continuum of vascular disease. The utilization of these agents, however, remains suboptimal. The drugs are not prescribed in many patients because of concerns ...

    journal_title:Pharmacotherapy

    pub_type: 评论,杂志文章

    doi:10.1592/phco.24.6.697.34731

    authors: Epstein BJ

    更新日期:2004-05-01 00:00:00

  • Management of herpesvirus infections in the healthy host.

    abstract::Human herpesvirus infections continue to be a concern in immunocompetent as well as immunocompromised hosts. They are often life threatening in the immunocompromised patient. In the healthy immunocompetent person the infections tend to be self-limited, although they can directly or indirectly cause periods of severe d...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Dudley MN

    更新日期:1995-09-01 00:00:00

  • Key articles and guidelines in the primary prevention of ischemic stroke.

    abstract::Ischemic stroke is a prevalent disease with a large burden on the health system. Preventive strategies, therefore, are paramount. Primary prevention is aimed at reducing the risk of stroke in asymptomatic people. The most effective prevention is through control of modifiable risk factors. Due to the large amount of li...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.1255

    authors: Baker WL,Marrs JC,Davis LE,Nutescu EA,Rowe AS,Ryan M,Splinter MY,Vardeny O,Fagan SC

    更新日期:2013-06-01 00:00:00

  • Strategies in the management of acute myocardial infarction.

    abstract::Clinical trials continue to evaluate the pharmacologic management of myocardial infarction for benefits in mortality, degree of infarct artery patency, and frequency of reocclusion. The discovery of thrombus formation in the development of the myocardial infarction renewed interest in thrombolytic therapy. In appropri...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Talbert RL

    更新日期:1996-09-01 00:00:00

  • Spontaneous Hemopericardium in a Patient Receiving Apixaban Therapy: First Case Report.

    abstract::Apixaban, a direct factor Xa inhibitor, is a novel oral anticoagulant (NOAC) indicated for prevention of embolic events in patients with nonvalvular atrial fibrillation. The agent is associated with a lower risk of bleeding compared with vitamin K antagonists such as warfarin. Hemopericardium is a life-threatening ble...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1602

    authors: Sigawy C,Apter S,Vine J,Grossman E

    更新日期:2015-07-01 00:00:00